EMA Backs Sanofi’s Teizeild For Type 1 Diabetes, Company Holds Fire On Extended Indication In EU

 
• By Neena Brizmohun
  
Diabetes awareness blue ribbon with red blood
Sanofi's diabetes immunotherapy could be approved in the EU soon (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet